[HTML][HTML] Genetic variants and breast carcinoma susceptibility: Unveiling the role of MTHFR (rs1801131, rs1801133) and TP53 (rs1042522)
WE Nouh, EF El Azab, EA Oraby, SM Ahmed… - Gene, 2025 - Elsevier
Background The contribution of MTHFR and TP53 genetic variants to breast carcinoma (BC)
susceptibility has been examined, but their findings have been inconclusive. This work is …
susceptibility has been examined, but their findings have been inconclusive. This work is …
DFT theoretical calculations on (Z)-2-hydroxy-N′-(4-oxo-1, 3-thiazolidin-2-ylidene) benzohydrazide as a methylene tetrahydrofolatereductase inhibitor: An in silico …
In this study,(Z)-2-hydroxy-N′-(4-oxo-1, 3-thiazolidin-2-ylidene) benzohydrazide (HTBH)
was theoretically studied. The B3LYP/6-311G (d, p) level of calculation was used to …
was theoretically studied. The B3LYP/6-311G (d, p) level of calculation was used to …